Meta-analysis: Diagnostic Accuracy of AntiCyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis

@article{Nishimura2007MetaanalysisDA,
  title={Meta-analysis: Diagnostic Accuracy of AntiCyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis},
  author={K. Nishimura and D. Sugiyama and Y. Kogata and Goh Tsuji and Takashi Nakazawa and S. Kawano and Katsuyasu Saigo and A. Morinobu and M. Koshiba and K. Kuntz and I. Kamae and S. Kumagai},
  journal={Annals of Internal Medicine},
  year={2007},
  volume={146},
  pages={797-808}
}
  • K. Nishimura, D. Sugiyama, +9 authors S. Kumagai
  • Published 2007
  • Medicine
  • Annals of Internal Medicine
    • Context Are autoantibodies against cyclic citrullinated peptide (CCP) better serum markers for rheumatoid arthritis than rheumatoid factor (RF)? Contribution This meta-analysis of 86 studies found that the positive likelihood ratio for anti-CCP antibody was greater than that for IgM RF for identifying patients with rheumatoid arthritis (12.5 vs. 4.9). Sensitivity was similar for the 2 tests, although specificity of anti-CCP antibody (95%) was higher than specificity of IgM RF (85%). Cautions… CONTINUE READING
    View on PubMed
    doi.org
    303 Citations
    Highly Influential Citations
    6
    Background Citations
    40
    Methods Citations
    2
    Results Citations
    5
    303 Citations
    Citation Type

    Citation Type

    Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
    • 21
    Diagnostic utility of anti-citrullinated protein antibody and its comparison with rheumatoid factor in rheumatoid arthritis.
    • 9
    Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios
    • 17
    • Highly Influenced
    A Comparative Assessment of the Diagnostic Value of Anti-cyclicCitrullinated Peptide Antibodies and Rheumatoid Factor in RheumatoidArthritis
    • 7
    The diagnostic utility of rheumatoid factor and anticitrullinated protein antibody for rheumatoid arthritis in the Indian population
    The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis
    • 24
    • PDF
    Ethnic differences in the prognostic utility of rheumatoid factor isotypes and anticyclic citrullinated peptides in rheumatoid arthritis patients: a cross-sectional study
    Ethnic differences in the prognostic utility of rheumatoid factor isotypes and anticyclic citrullinated peptides in rheumatoid arthritis patients: a cross-sectional study
    • 5
    • PDF
    Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value.
    • 29
    Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis
    • 429

    References

    SHOWING 1-10 OF 122 REFERENCES
    Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors.
    • 164
    • PDF
    Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
    • 175
    • Highly Influential
    • PDF
    Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis.
    • 287
    • Highly Influential
    • PDF
    Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?
    • 25
    • Highly Influential
    Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
    • 89
    • Highly Influential
    Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.
    • 186
    Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis.
    • 202
    • Highly Influential
    • PDF
    Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients.
    • 26
    Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis
    • 429
    The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
    • 1,429
    • Highly Influential